AlzeCure Pharma (Sweden) Performance
| ALZCUR Stock | SEK 2.80 0.33 13.36% |
AlzeCure Pharma holds a performance score of 15 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.72, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning AlzeCure Pharma are expected to decrease by larger amounts. On the other hand, during market turmoil, AlzeCure Pharma is expected to outperform it. Use AlzeCure Pharma downside variance, as well as the relationship between the accumulation distribution and market facilitation index , to analyze future returns on AlzeCure Pharma.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AlzeCure Pharma are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, AlzeCure Pharma sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 112.4 M | |
| Total Cashflows From Investing Activities | -54 K |
AlzeCure |
AlzeCure Pharma Relative Risk vs. Return Landscape
If you would invest 119.00 in AlzeCure Pharma on December 23, 2024 and sell it today you would earn a total of 161.00 from holding AlzeCure Pharma or generate 135.29% return on investment over 90 days. AlzeCure Pharma is generating 1.8409% of daily returns and assumes 9.4539% volatility on return distribution over the 90 days horizon. Simply put, 84% of stocks are less volatile than AlzeCure, and 63% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
AlzeCure Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AlzeCure Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AlzeCure Pharma, and traders can use it to determine the average amount a AlzeCure Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1947
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ALZCUR | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.45 actual daily | 84 84% of assets are less volatile |
Expected Return
| 1.84 actual daily | 37 63% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average AlzeCure Pharma is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AlzeCure Pharma by adding it to a well-diversified portfolio.
AlzeCure Pharma Fundamentals Growth
AlzeCure Stock prices reflect investors' perceptions of the future prospects and financial health of AlzeCure Pharma, and AlzeCure Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AlzeCure Stock performance.
| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Current Valuation | 173.51 M | |||
| Shares Outstanding | 59.19 M | |||
| Price To Book | 6.62 X | |||
| EBITDA | (77.2 M) | |||
| Cash And Equivalents | 222.05 M | |||
| Cash Per Share | 5.88 X | |||
| Book Value Per Share | 0.63 X | |||
| Cash Flow From Operations | (70.64 M) | |||
| Earnings Per Share | (1.78) X | |||
| Total Asset | 45.65 M | |||
About AlzeCure Pharma Performance
By analyzing AlzeCure Pharma's fundamental ratios, stakeholders can gain valuable insights into AlzeCure Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AlzeCure Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AlzeCure Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.Things to note about AlzeCure Pharma performance evaluation
Checking the ongoing alerts about AlzeCure Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AlzeCure Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AlzeCure Pharma is way too risky over 90 days horizon | |
| AlzeCure Pharma appears to be risky and price may revert if volatility continues | |
| AlzeCure Pharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| AlzeCure Pharma has accumulated about 222.05 M in cash with (70.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company shares are held by company insiders |
- Analyzing AlzeCure Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AlzeCure Pharma's stock is overvalued or undervalued compared to its peers.
- Examining AlzeCure Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AlzeCure Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AlzeCure Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AlzeCure Pharma's stock. These opinions can provide insight into AlzeCure Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |